A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
BACKGROUND
Blue light sources have been shown to be effective in the treatment of mild to moderate inflammatory acne vulgaris lesions.


OBJECTIVE
We evaluated the safety and efficacy of a new blue light source in the treatment of mild to moderate inflammatory acne vulgaris in comparison to topical 1% clindamycin solution.


RESULTS
Blue light therapy reduced inflammatory acne vulgaris lesions by an average of 34%, as compared to 14% for topical 1% clindamycin solution.


CONCLUSIONS
The blue light source presented in this report is a safe and effective treatment option available to our patients with mild to moderate inflammatory acne lesions.
Gold
Michael H
MH
Gold Skin Care Center, Tennessee Clinical Research Center Nashville, TN 37215, USA. drgold@goldskincare.com
Rao
Jaggi
J
Goldman
Mitchel P
MP
Bridges
Tancy M
TM
Bradshaw
Virginia L
VL
Boring
Molly M
MM
Guider
April N
AN
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000628:therapy*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019999:Pharmaceutical Solutions; D010778:Photochemotherapy; D010865:Pilot Projects
D000900:Anti-Bacterial Agents; D019999:Pharmaceutical Solutions; D002981:Clindamycin